AustraliaDaily Briefs

Daily Brief Australia: Virgin Money UK Plc, Latin Resources, Rio Tinto Ltd, Opthea Ltd, Nickel Industries and more

In today’s briefing:

  • Nationwide/Virgin Money (VUK AU): At The Pointy End Of The Offer
  • Latin Resources (LRS AU): Pilbara Minerals’ All-Scrip Offer
  • Selected European HoldCos and DLC: August’24 Report
  • Opthea (OPT AU): Getting Closer to Commercialization of First Drug; Fund Raising Adds to Confidence
  • Morning Views Asia: Meituan, New World Development, Nickel Industries


Nationwide/Virgin Money (VUK AU): At The Pointy End Of The Offer

By David Blennerhassett

  • Back on the 21st March, Virgin Money UK (VUK AU/VMUK LN), UK’s sixth largest retail bank, entered into a Scheme with Nationwide Building Society, at 220 pence/share, in cash.
  • The consideration is a solid 38% premium to undisturbed. And shareholders backed terms at the 22nd May Court Meeting. Plus UK’s CMA signed off on the 19th July
  • What now? FCA/PRA approvals are the key remaining conditions. These regulatory approvals are imminent.

Latin Resources (LRS AU): Pilbara Minerals’ All-Scrip Offer

By Arun George

  • On 15 August, Latin Resources (LRS AU) disclosed a binding offer from Pilbara Minerals (PLS AU) at 0.07 PLS share per LRS share, a 66.3% premium to the undisturbed price. 
  • The key condition is LRS shareholder approval. No disinterested shareholder holds the 25% blocking stake, and low retail ownership lowers the headcount test risk. 
  • The Salinas definitive feasibility study, expected in September, provides option value. A strong result could draw a competing offer or force PLS into sweetening terms.  

Selected European HoldCos and DLC: August’24 Report

By Jesus Rodriguez Aguilar

  • Discounts to NAV of covered holdcos did not follow a clear trend during August. Discounts to NAV: C.F.Alba, 46.2% (vs. 45.3% as of August 9); GBL, 41.1% (vs. 42.2%); 
  • Heineken Holding, 16.5% (vs. 16%); Industrivärden C, 1.7% (vs. 2.2%); Investor B, 1.9% (vs.7.5%); Porsche Automobile Holding, 35.7% (vs. 34.6%). Rio DLC spread tightened to 19.8% (vs. 22.1%).
  • What seems interesting (unchanged views): Porsche SE vs. listed assets and the Rio DLC (long RIO LN/short RIO AU).

Opthea (OPT AU): Getting Closer to Commercialization of First Drug; Fund Raising Adds to Confidence

By Tina Banerjee

  • Opthea Ltd (OPT AU) completed enrollment in two Phase 3 trials for sozinibercept in wet AMD. Topline data from these trials are expected by mid-2025.
  • During FY24, Opthea raised $295M to extend runway through topline data readouts of Phase 3 clinical trials. Further, in July, Opthea raised $38M through retail entitlement offer.
  • Although Opthea is well-funded through mid-2025, any fund requirement beyond that period will be easier to meet amid lower interest rate scenario.

Morning Views Asia: Meituan, New World Development, Nickel Industries

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars